Accessibility Menu
OptiNose logo

OptiNose(NASDAQ) OPTN

This security has been delisted. This page is retained for historical reference.

OptiNose last closing stock price
MetricPriceDate
Last closeUSD 9.602025-05-20
OptiNose stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.59%USD 9.452025-05-13
1 month+4.69%USD 9.172025-04-17
3 month+61.34%USD 5.952025-02-19
Year to date+43.71%USD 6.682024-12-31
1 year-46.67%USD 18.002024-05-20
3 year-67.01%USD 29.102022-05-20
5 year-85.29%USD 65.252020-05-21
Since inception-96.63%USD 285.002017-10-13

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

OPTN Financials

Key Financial Metrics (TTM)

Gross Margin

90.76%

Operating Margin

-20.86%

Net Income Margin

-27.54%

Return on Equity

33.93%

Return on Capital

-18.42%

Return on Assets

-16.73%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$74.11M

Operating Income

-$15.84M

EBITDA

$290.00K

Operating Cash Flow

-$34.21M

Capital Expenditure

-$50.00K

Free Cash Flow

-$34.26M

Cash & ST Invst.

$72.93M

Total Debt

$127.21M

OptiNose Performance Analysis

OptiNose annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 74,652,000N/A
20222022-12-31USD 76,276,0002.2%
20232023-12-31USD 70,987,000-6.9%
20242024-12-31USD 78,226,00010.2%
OptiNose sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3037.7%
Q32024-09-30-0.3%
Q42024-12-319.7%
Q12025-03-31-17.4%
OptiNose annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -21.71N/A
20222022-12-31USD -13.07-39.8%
20232023-12-31USD -4.75-63.7%
20242024-12-31USD -2.12-55.3%
OptiNose sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3043.9%
Q32024-09-30103.2%
Q42024-12-31-191.4%
Q12025-03-31-6113.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$18.51M

+24.4%

Gross Profit

$16.76M

+23.5%

Gross Margin

90.55%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

127

N/A

Net Income

-$22.42M

-59.4%

EBITDA

-$7.53M

+16.5%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

$72.93M

+41.2%

Total Debt

$127.21M

-3.2%

Accounts Receivable

$23.14M

+62.7%

Inventory

$11.30M

+9.5%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$128.39M

+17608.4%

Return on Assets

-16.73%

N/A

Return on Invested Capital

47.96%

N/A

Free Cash Flow

-$11.55M

+47.6%

Operating Cash Flow

-$11.55M

+47.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FVEFive Star Senior Living Inc.
$2.94+2.44%
UPXIUpexi, Inc.
$0.80-0.73%
JNCEJounce Therapeutics, Inc.
$1.88+0.00%
MIROMiromatrix Medical Inc.
$3.39+0.59%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
AALAmerican Airlines Group
$14.48+0.07%
CLFCleveland-Cliffs
$11.93+0.09%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.